These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 26465660

  • 21. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM, Akcakanat A, Adkins F, Evans K, Chen H, Wei C, Milton DR, Li Y, Do KA, Janku F, Meric-Bernstam F.
    Oncotarget; 2015 Aug 14; 6(23):19500-13. PubMed ID: 25944619
    [Abstract] [Full Text] [Related]

  • 22. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A, Salmon JM, Martin BP, Stanley K, Johnstone RW.
    Oncogene; 2014 Nov 20; 33(47):5415-23. PubMed ID: 24292681
    [Abstract] [Full Text] [Related]

  • 23. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC, Chang TW, Tseng YL, Lee JC, Chang MC.
    Carcinogenesis; 2014 Jul 20; 35(7):1481-90. PubMed ID: 24403312
    [Abstract] [Full Text] [Related]

  • 24. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP, Yang YX, Liu QL, Zhou ZW, Pan ST, He ZX, Zhang X, Yang T, Pan SY, Duan W, He SM, Chen XW, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Jul 20; 9():1027-62. PubMed ID: 25733818
    [Abstract] [Full Text] [Related]

  • 25. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
    Mohapatra P, Satapathy SR, Das D, Siddharth S, Choudhuri T, Kundu CN.
    Toxicol Appl Pharmacol; 2014 Mar 15; 275(3):221-31. PubMed ID: 24467951
    [Abstract] [Full Text] [Related]

  • 26. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W, Lu Z, Luo RZ, Zhang X, Seto E, Liao WS, Yu Y.
    Int J Cancer; 2007 Apr 15; 120(8):1664-8. PubMed ID: 17230502
    [Abstract] [Full Text] [Related]

  • 27. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX, Fang JY, Lu J, Qiu DK.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):312-7. PubMed ID: 15059516
    [Abstract] [Full Text] [Related]

  • 28. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, Tabbara S, Latham P, Teal CB, Man YG, Siegel RS, Brem RF, Fu SW.
    Oncotarget; 2016 Jan 05; 7(1):293-307. PubMed ID: 26588055
    [Abstract] [Full Text] [Related]

  • 29. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Qin G, Xu F, Qin T, Zheng Q, Shi D, Xia W, Tian Y, Tang Y, Wang J, Xiao X, Deng W, Wang S.
    Oncotarget; 2015 Dec 08; 6(39):41794-808. PubMed ID: 26540629
    [Abstract] [Full Text] [Related]

  • 30. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F, Wolffe AP.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512
    [Abstract] [Full Text] [Related]

  • 31. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT.
    J Nutr Biochem; 2015 Jun 24; 26(6):675-85. PubMed ID: 25792283
    [Abstract] [Full Text] [Related]

  • 32. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA, Hussain A, Sundaram MK, Alalami U, Gunasekera D, Ramesh L, Hamza A, Quraishi U.
    Oncol Rep; 2015 Apr 24; 33(4):1976-84. PubMed ID: 25682960
    [Abstract] [Full Text] [Related]

  • 33. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H, Vieth E, Lee J, Segar M, Liu Y, Nephew KP, Matei D.
    Epigenetics; 2014 Nov 24; 9(11):1461-72. PubMed ID: 25470663
    [Abstract] [Full Text] [Related]

  • 34. Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition.
    Song GQ, Zhao Y.
    Oncol Rep; 2015 Feb 24; 33(2):669-74. PubMed ID: 25420482
    [Abstract] [Full Text] [Related]

  • 35. Regulation of MDA-MB-231 cell proliferation by GSK-3β involves epigenetic modifications under high glucose conditions.
    Gupta C, Kaur J, Tikoo K.
    Exp Cell Res; 2014 May 15; 324(1):75-83. PubMed ID: 24704462
    [Abstract] [Full Text] [Related]

  • 36. Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu mice.
    Joung KE, Min KN, An JY, Kim DK, Kong G, Sheen YY.
    Cancer Res; 2006 May 15; 66(10):5394-402. PubMed ID: 16707467
    [Abstract] [Full Text] [Related]

  • 37. Antimutagenic effects of centchroman--a contraceptive and a candidate drug for breast cancer in multiple mutational assays.
    Giri AK, Mukhopadhyay A, Sun J, Hsie AW, Ray S.
    Mutagenesis; 1999 Nov 15; 14(6):613-20. PubMed ID: 10567037
    [Abstract] [Full Text] [Related]

  • 38. Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro.
    Smolkova B, Miklikova S, Kajabova VH, Babelova A, Yamani NE, Zduriencikova M, Fridrichova I, Zmetakova I, Krivulcik T, Kalinkova L, Matuskova M, Kucerova L, Dusinska M.
    Neoplasma; 2016 Nov 15; 63(6):901-910. PubMed ID: 27565328
    [Abstract] [Full Text] [Related]

  • 39. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G.
    Cancer Res; 2009 May 01; 69(9):3779-87. PubMed ID: 19383923
    [Abstract] [Full Text] [Related]

  • 40. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
    Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG.
    Cancer Res; 2007 Jan 01; 67(1):194-201. PubMed ID: 17210699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.